Paulson & Co. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Paulson & Co. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2017$2,404,000
+311.6%
27,500
+75.3%
0.03%
+312.5%
Q1 2017$584,000
+21.2%
15,6900.0%0.01%
+33.3%
Q4 2016$482,000
-91.5%
15,690
-81.4%
0.01%
-90.2%
Q3 2016$5,666,000
+30.5%
84,500
-42.0%
0.06%
+38.6%
Q2 2016$4,343,000
+110.3%
145,800
+107.4%
0.04%
+193.3%
Q1 2016$2,065,000
-42.7%
70,300
+52.8%
0.02%
-31.8%
Q4 2015$3,606,00046,0000.02%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
View complete list of PUMA BIOTECHNOLOGY INC shareholders